U.S. Hotel and Resort REITs Stock News

NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Adaptive Biotechnologies (ADPT) Is Down 11.9% After MRD-Led Earnings Beat And Tax-Driven Insider Sales - Has The Bull Case Changed?

In March 2026, Adaptive Biotechnologies reported fourth-quarter 2025 results that beat analyst expectations, with revenue growth led by its Minimal Residual Disease (MRD) business, while several senior executives sold shares largely to cover tax obligations linked to vested equity awards. This combination of stronger MRD performance and insider sales tied mainly to tax withholding offers insight into how operational momentum and routine executive transactions can coexist without necessarily...
NYSE:BCC
NYSE:BCCTrade Distributors

Does Boise Cascade’s (BCC) Lean Inventory Strategy Hint at Lasting Efficiency Gains or Hidden Constraints?

Recently, Boise Cascade reported quarterly earnings and revenue that came in ahead of analyst expectations, even as it faced typical seasonal softness and broader market headwinds in its building products markets. The company also highlighted progress on its Thorsby i-line expansion, disciplined operational controls, and lean channel inventories, which together point to a tighter, more efficient operating base for its engineered wood and distribution businesses. Next, we'll examine how this...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

Will Revolve Los Angeles Launch Redefine Revolve Group’s (RVLV) Luxury Brand Narrative?

In March 2026, Revolve Group, Inc. launched Revolve Los Angeles, its first namesake fashion house, debuting a XXS–XL collection priced around US$200–US$3,500 and sold exclusively on Revolve and FWRD. The move expands Revolve’s in-house brand portfolio into higher-end, couture-influenced ready-to-wear, potentially deepening customer engagement around luxury, Los Angeles-inspired fashion. Next, we’ll examine how Revolve Los Angeles, as a higher-end in-house label, could influence Revolve...
NYSE:HESM
NYSE:HESMOil and Gas

Did Hess Midstream’s (HESM) Debt-Funded Buyback Just Redefine Its Capital Return Strategy?

Earlier this month, Hess Midstream LP announced that its Board authorized a share repurchase program and entered into an agreement with JPMorgan Chase Bank to buy back up to US$42 million of Class A shares, funded through its existing revolving credit facility, with repurchased shares to be cancelled and final settlement expected by March 2026. This accelerated share repurchase arrangement not only reduces the public float but also underscores management’s willingness to use balance sheet...
NYSE:MC
NYSE:MCCapital Markets

Do Moelis’ (MC) Strong Earnings and Neutral Ratings Point To Different Stories On Margins?

In recent days, Moelis & Company reported strong Q4 earnings and highlighted its strongest coverage platform to date, with management emphasizing momentum and long-term value creation. At the same time, several major banks reiterated neutral views on Moelis, revealing a tension between upbeat internal commentary and cautious external assessments. Next, we'll examine how upbeat earnings alongside cautious analyst sentiment may influence Moelis' existing investment narrative around growth...
NYSE:USB
NYSE:USBBanks

Should U.S. Bancorp’s New Long-Dated Debt and Wealth Role Reshape USB’s Investor Narrative?

In early March 2026, U.S. Bancorp expanded its funding options with a series of new senior unsecured fixed-rate notes maturing between 2031 and 2046, while also declaring regular quarterly and semi-annual dividends on its common and multiple preferred share classes payable on April 15, 2026. The creation of a President of Emerging Affluent Wealth Management role, alongside fresh bond issuance and an updated universal shelf registration, points to a coordinated push to deepen relationships...
NYSE:UI
NYSE:UICommunications

How Investors Are Reacting To Ubiquiti (UI) Gear Linked To Epstein Island Surveillance Use

In recent days, Department of Justice documents revealed that Ubiquiti’s networking equipment was used for communications and surveillance on Jeffrey Epstein’s private island, drawing public and regulatory attention to the company’s role. This association creates a new layer of reputational and legal risk for Ubiquiti, complicating an investment story previously focused on balance sheet strength and earnings momentum. We’ll now examine how this emerging reputational and regulatory risk...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

How Opendoor’s Strong Q4 and Evolving Model Will Impact Opendoor Technologies (OPEN) Investors

In recent days, Opendoor Technologies reported Q4 revenue that exceeded analyst expectations while guiding to a roughly 10% year-on-year revenue decline for Q1 and an adjusted EBITDA loss. Management highlighted progress in unit economics, growth of its low-capital Cash Plus offering, cost reductions, and a new 4.99% beta mortgage program that together point to an evolving, more flexible business model. Next, we’ll examine how Opendoor’s stronger-than-expected Q4 revenue and improved unit...
NasdaqGM:AMAL
NasdaqGM:AMALBanks

What Amalgamated Financial (AMAL)'s In-Line Q4 Earnings and Insider Sales Mean For Shareholders

On March 10, 2026, Amalgamated Financial Corp reported fourth-quarter 2025 earnings with earnings per share of $0.91, matching analyst expectations, while quarterly revenue of $87.91 million modestly exceeded forecasts. On the same day, Executive Vice President and Chief Legal Officer Mandy Tenner sold 776 shares under a Rule 10b5-1 plan, adding to a year of insider selling that raises questions about how leadership is managing personal holdings alongside solid operating results. Next,...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Ascendis Pharma (ASND) Is Down 5.8% After New Two-Year YUVIWEL Achondroplasia Data Release – Has The Bull Case Changed?

Ascendis Pharma A/S recently reported two-year data from its pivotal ApproaCH Trial, showing that once-weekly TransCon CNP (YUVIWEL) maintained consistent improvements in growth and body proportionality in children with achondroplasia, with a generally well-tolerated safety profile and strong trial retention. These longer-term results reinforce YUVIWEL’s clinical profile shortly after its U.S. approval for pediatric achondroplasia and ahead of a key European regulatory decision expected...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

A Look At Playtika Holding (PLTK) Valuation After Leadership Roles Shift To Antokol And Lee

Why the leadership reshuffle at Playtika Holding (PLTK) matters for shareholders Playtika Holding (PLTK) is reshaping its senior ranks, with long serving President and CFO Craig Abrahams set to depart on April 1, 2026, and responsibilities shifting to existing insiders. Board chair Robert Antokol will add the President role. Senior finance leader Tae Lee will step in as acting CFO after several years overseeing corporate finance and investor relations. See our latest analysis for Playtika...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Assessing Netskope (NTSK) Valuation After Netskope One AI Security Launch And Healthcare Integrations

Netskope (NTSK) is back in focus after launching its Netskope One AI Security suite, alongside fresh earnings results and new healthcare integrations that together highlight how it is positioning around enterprise AI security. See our latest analysis for Netskope. Despite the launch of Netskope One AI Security and new healthcare integrations, Netskope’s short term share price return has been mixed. The 7 day share price return is 20.75% and the 90 day share price return is 51.40%, which...
NasdaqGS:SATS
NasdaqGS:SATSMedia

How EchoStar’s 2025 Losses and Wireless Pivot Could Reshape EchoStar (SATS) Investors’ Expectations

EchoStar Corporation has released its full-year 2025 results, reporting revenue of US$15.00 billion, a net loss of US$14.50 billion, and basic and diluted losses per share from continuing operations of US$50.41, all widening significantly from the prior year. Alongside these weak financials, investor attention has shifted toward EchoStar’s move away from declining pay-TV operations toward wireless and MVNO services, and to the potential importance of its non-operating assets such as its...
NYSE:PBF
NYSE:PBFOil and Gas

A Look At PBF Energy (PBF) Valuation After Earnings Beat And Major Insider Share Sales

PBF Energy (PBF) is back in focus after fourth quarter 2025 adjusted earnings per share of $0.66 came in well above expectations, alongside sizeable insider share sales that give investors fresh information to weigh. See our latest analysis for PBF Energy. The strong fourth quarter surprise, heavy insider selling and upcoming Piper Sandler conference appearance have all coincided with powerful momentum. This includes a 30 day share price return of 25.94% and a 1 year total shareholder return...
NYSE:SOC
NYSE:SOCOil and Gas

Sable Offshore (SOC) Is Up 18.8% After Trump-Era DPA Order to Restart California Assets

The Trump administration previously issued an executive order under the Defense Production Act directing Sable Offshore to restart its long-idled Santa Ynez offshore unit and associated California pipelines, aiming to bolster fuel supplies during the conflict with Iran. This federal push, alongside ongoing court challenges and questions over permitting and safety, has turned Sable Offshore into a high-profile test case for how far Washington can go in overriding state-level environmental...
NasdaqGS:HTO
NasdaqGS:HTOWater Utilities

Will Equity Raise And Baird Outperform Call Reshape H2O America's (HTO) Acquisition-Driven Narrative?

H2O America recently completed a follow-on equity offering of US$608.70 million, issuing 11,484,824 common shares at US$53 each with a US$1.7225 discount per share to help fund an acquisition. At the same time, Baird initiated coverage on H2O America with an Outperform rating, signaling increased institutional attention just as the company raises fresh capital for expansion. Next, we’ll explore how this sizable equity raise to fund an acquisition could reshape H2O America’s previously...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

A Look At Willis Towers Watson (WTW) Valuation After Qover Partnership Expands Embedded Insurance Capabilities

Willis Towers Watson (WTW) shares are in focus after the company expanded its GB Affinity technology ecosystem through a partnership with Qover, targeting embedded insurance solutions that are integrated directly into customer journeys across multiple sectors. See our latest analysis for Willis Towers Watson. Despite the Qover partnership putting the focus on Willis Towers Watson’s technology capabilities, the shares trade at US$289.54 after a 12.2% decline in the 3 month share price return,...
NasdaqGS:INNV
NasdaqGS:INNVHealthcare

A Look At InnovAge Holding (INNV) Valuation After Analyst Upgrade And Shifting Sentiment

InnovAge Holding (INNV) has just been upgraded to a higher Zacks rank, supported by rising earnings estimate revisions and a hammer chart pattern that points to improving sentiment and renewed attention on the stock. See our latest analysis for InnovAge Holding. At a share price of $8.39, InnovAge Holding has seen short term share price pressure, with a 7 day share price return of a 4.22% decline, alongside strong recent momentum reflected in a 90 day share price return of 51.17% and a 1 year...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

Assessing VEON (NasdaqGS:VEON) Valuation After Earnings Jump And Digital Growth-Fueled Share Price Reaction

VEON (VEON) shares reacted to fresh fourth quarter and full year 2025 results, where record digital revenue growth, higher group revenue and EBITDA, a new share buyback program, and 2026 guidance drew investor attention. See our latest analysis for VEON. VEON’s share price jumped 14.2% on the day of the results, even though the 30 day and year to date share price returns of 3.5% and 4% point to fading short term momentum. At the same time, the 3 year total shareholder return of about 215%...
NYSE:APO
NYSE:APODiversified Financial

How Investors Are Reacting To Apollo Global Management (APO) Launching a DC-Focused Private Credit LTAF

Apollo Global Management has launched the CG Apollo Global Diversified Credit LTAF, a newly FCA‑authorized multi-sector private credit fund offering UK defined contribution schemes access to a diversified global credit portfolio in a semi-liquid format. This fund is the first sub-fund in Apollo’s broader Private Markets LTAF umbrella and extends its push to bring institutional-grade private market retirement solutions to defined contribution plans across the UK, US and Europe. We’ll now...
NYSE:ADC
NYSE:ADCRetail REITs

Is Agree Realty (ADC) Offering Value After Mixed Returns And Conflicting DCF And P/E Signals

Wondering if Agree Realty at around US$79.20 is offering fair value or a potential bargain? This article focuses squarely on what the current price might imply about the stock. The share price shows mixed recent returns, with a 2.3% decline over the last 7 days, a 1.4% gain over 30 days, and returns of 9.8% year to date, 7.0% over 1 year, 31.6% over 3 years, and 48.2% over 5 years. These moves are set against ongoing interest in high quality real estate investment trusts, where income...
NasdaqGS:MBX
NasdaqGS:MBXPharmaceuticals

A Look At MBX Biosciences (MBX) Valuation After Recent Share Price Pullback

Why MBX Biosciences is on investors’ radar today MBX Biosciences (MBX) has attracted attention after a recent move in its share price, with the stock now around $28 following mixed short term returns, including a decline over the past month and a modest gain over the past 3 months. See our latest analysis for MBX Biosciences. That recent pullback, with a 30 day share price return of around 26% decline and year to date share price return of around 8% decline, contrasts sharply with a very...
NYSE:AB
NYSE:ABCapital Markets

How AllianceBernstein’s Rising Private Markets AUM and Modest Outflows May Shape AB’s Investor Story

Earlier in March 2026, AllianceBernstein Holding reported that preliminary assets under management rose to US$880 billion in February from US$875 billion in January, mainly due to market appreciation despite modest net outflows. The firm also reported that private markets assets under management reached US$82 billion, a year-over-year increase described as 18%, alongside more than US$140 billion in annual sales even as active equities saw net outflows. We’ll now consider how this fresh...
NYSE:CFG
NYSE:CFGBanks

Assessing Citizens Financial Group (CFG) Valuation After Recent Share Price Pullback

Why Citizens Financial Group Is On Investors’ Radar Citizens Financial Group (CFG) has attracted attention after a roughly 14% decline over the past month, prompting investors to reassess the bank’s US$55.64 share price against its recent financial profile. See our latest analysis for Citizens Financial Group. That recent 14% one month share price decline sits against a 41.15% one year total shareholder return and a 101.79% three year total shareholder return, so recent momentum looks weaker...